MEA Fibrotic Diseases Treatment Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	157 Pages	Data Bridge Market Research	March, 2023	DAABD17862145

Best Price Guarantee
Price	from $3,500
Length	157 Pages
Publisher	Data Bridge Market Research
Published Date	March, 2023
SKU	DAABD17862145

MEA Fibrotic Diseases Treatment Market - Industry Trends and Forecast to 2030

Middle East and Africa Fibrotic Diseases Treatment Market, By Treatment (Medication, Organ Transplantation, Oxygen Therapy, Others), Application (Idiopathic Pulmonary Fibrosis, Hepatic Cirrhosis, Renal Fibrosis, Cutaneous Fibrosis, Others), End User (Hospitals, Specialty Clinics, Academic and Research Institutes, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Kuwait, Bahrain Israel, Rest of Middle East and Africa)

Market Definition

The term fibrosis describes the development of fibrous connective tissue as a reparative response to injury or damage. Fibrosis may refer to the connective tissue deposition that occurs as part of normal healing or to the excess tissue deposition that occurs as a pathological process. Diseases characterized by uncontrolled, progressive fibrosis include Idiopathic Pulmonary Fibrosis (IPF), Non-Alcoholic Steatohepatitis (NASH), and Systemic Sclerosis (SSc).

Fibrosis is a group of serious organ/tissue diseases that affect the tissue system. Fibrosis scars and thickens the tissue. It impacts the connecting tissue, for instance, in the lung and the alveoli (air sacs inside the lungs). The lung damage gradually gets worse over time. Hard, stiff lung tissues don’t expand as well as they should, making it harder to breathe. Pulmonary fibrosis may cause shortness of breath when you do routine tasks that never seemed tiring before.

Market Segmentation

The Middle East and Africa fibrotic diseases treatment market is categorized into four notable segments such as treatment, application, end user, and distribution channel.
• On the basis of treatment, the fibrotic diseases treatment market is segmented into medication, organ transplantation, oxygen therapy, and others
• On the basis of application, the fibrotic diseases treatment market is segmented into idiopathic pulmonary fibrosis, hepatic cirrhosis, renal fibrosis, cutaneous fibrosis, and others
• On the basis of end user, the fibrotic diseases treatment market is segmented into hospitals, specialty clinics, academic and research institutes, and others
• On the basis of distribution channel, the fibrotic diseases treatment market is segmented into hospital pharmacy, retail pharmacy, and others

Market Players

Some of the key market players in the Middle East and Africa fibrotic diseases treatment market are listed below:
• Boehringer Ingelheim International GmbH
• AbbVie Inc.
• Bristol-Myers Squibb Company
• BioMX
• Gilead Sciences, Inc.
• Teva Pharmaceutical Industries Ltd.
• Sandoz International GmbH

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Middle East & Africa Fibrotic Diseases Treatment Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Treatment Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market End User Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Porter's 5 Forces; 4.2 Pestel Analysis
5 Epidemiology: 5.1 Incidence Of All By Gender; 5.2 Treatment Rate; 5.3 Mortality Rate; 5.4 Drug Adherence And Therapy Switch Model; 5.5 Patient Treatment Success Rate
6 Industry Insights: 6.1 Patent Analysis; 6.2 Drug Treatment Rate By Matured Markets; 6.3 Demographic Trends: Impacts On All Incidence Rate; 6.4 Key Pricing Strategies; 6.5 Key Patient Enrollment Strategies
7 Mergers And Acquisitions: 7.1 Licensing:; 7.2 Commercialization Agreements
8 Pipeline Analysis: 8.1 Phase 1; 8.2 Phase 2; 8.3 Phase 3
9 Middle East & Africa Fibrotic Diseases Treatment Market, Regulations: 9.1 Fda Approvals; 9.2 Ema Approvals
10 Market Overview: 10.1 Drivers; 10.1.1 Rising Prevalence Of Fibrotic Diseases; 10.1.2 Increase In The Number Of People Smoking Cigarettes; 10.1.3 Technological Advancement In The Treatment Of Fibrosis Diseases; 10.2 Restraints; 10.2.1 High Cost Of Medication And Treatments; 10.2.2 Lack Of Effective Biomarkers And Diagnostic Tools For Early Detection And Monitoring Of Fibrotic Diseases; 10.3 Opportunities; 10.3.1 Rising Research And Development Activities; 10.3.2 Development Of New And More Effective Therapies For Fibrotic Diseases; 10.4 Challenges; 10.4.1 The Complex And Multifactorial Nature Of Fibrotic Diseases.; 10.4.2 High Rate Of Failure In Clinical Trials For Fibrotic Diseases, Which Can Result In Significant Costs And Delays In Drug Development
11 Middle East & Africa Fibrotic Diseases Treatment Market: By Treatment: 11.1 Overview; 11.2 Medication; 11.2.1 Intedanib (Ofev); 11.2.2 Pirfenidone (Esbriet); 11.3 Organ Transplantation; 11.4 Oxygen Therapy; 11.5 Others
12 Middle East & Africa Fibrotic Diseases Treatment Market, By Application: 12.1 Overview; 12.2 Idiopathic Pulmonary Fibrosis; 12.3 Hepatic Cirrhosis; 12.4 Renal Fibrosis; 12.5 Cutaneous Fibrosis; 12.6 Others
13 Middle East & Africa Fibrotic Diseases Treatment Market, By End User: 13.1 Overview; 13.2 Hospitals; 13.3 Specialty Clinics; 13.4 Academic And Research Institutes; 13.5 Others
14 Middle East & Africa Fibrotic Diseases Treatment Market, By Distribution Channel: 14.1 Overview; 14.2 Hospital Pharmacy; 14.3 Retail Pharmacy; 14.4 Others
15 Middle East & Africa Fibrotic Diseases Treatment Market, By Region: 15.1 Middle East And Africa; 15.1.1 South Africa; 15.1.2 Saudi Arabia; 15.1.3 U.A.E; 15.1.4 Egypt; 15.1.5 Kuwait; 15.1.6 Israel; 15.1.7 Bahrain; 15.1.8 Rest Of Middle East And Africa
16 Middle East & Africa Fibrotic Diseases Treatment Market, Company Landscape: 16.1 Company Share Analysis: Middle East & Africa
17 Swot Analysis
18 Company Profile: 18.1 Boehringer Ingelheim International Gmbh; 18.1.1 Company Snapshot; 18.1.2 Revenue Analysis; 18.1.3 Company Share Analysis; 18.1.4 Product Portfolio; 18.1.5 Recent Developments; 18.2 Genentech, Inc.; 18.2.1 Company Snapshot; 18.2.2 Company Share Analysis; 18.2.3 Product Portfolio; 18.2.4 Recent Developments; 18.3 Sandoz International Gmbh; 18.3.1 Company Snapshot; 18.3.2 Company Share Analysis; 18.3.3 Product Portfolio; 18.3.4 Recent Developments; 18.4 Teva Pharmaceutical Industries Ltd.; 18.4.1 Company Snapshot; 18.4.2 Revenue Analysis; 18.4.3 Company Share Analysis; 18.4.4 Product Portfolio; 18.4.5 Recent Developments; 18.5 Accord Healthcare U.S.; 18.5.1 Company Snapshot; 18.5.2 Company Share Analysis; 18.5.3 Product Portfolio; 18.5.4 Recent Developments; 18.6 Abbvie Inc.; 18.6.1 Company Snapshot; 18.6.2 Revenue Analysis; 18.6.3 Product Portfolio; 18.6.4 Recent Developments; 18.7 Alpine Immune Sciences; 18.7.1 Company Snapshot; 18.7.2 Revenue Analysis; 18.7.3 Product Portfolio; 18.7.4 Recent Developments; 18.8 Bellbrook Labs; 18.8.1 Company Snapshot; 18.8.2 Product Portfolio; 18.8.3 Recent Developments; 18.9 Biomx; 18.9.1 Company Snapshot; 18.9.2 Revenue Analysis; 18.9.3 Product Portfolio; 18.9.4 Recent Developments; 18.10 Bristol-myers Squibb Company; 18.10.1 Company Snapshot; 18.10.2 Revenue Analysis; 18.10.3 Product Portfolio; 18.10.4 Recent Developments; 18.11 Camber Pharmaceuticals, Inc.; 18.11.1 Company Snapshot; 18.11.2 Product Portfolio; 18.11.3 Recent Developments; 18.12 Enveda; 18.12.1 Company Snapshot; 18.12.2 Product Portfolio; 18.12.3 Recent Developments; 18.13 Gilead Sciences, Inc.; 18.13.1 Company Snapshot; 18.13.2 Revenue Analysis; 18.13.3 Product Portfolio; 18.13.4 Recent Developments; 18.14 Intercept Pharmaceuticals, Inc.; 18.14.1 Company Snapshot; 18.14.2 Revenue Analysis; 18.14.3 Product Portfolio; 18.14.4 Recent Developments; 18.15 Kither Biotech S.R.L.; 18.15.1 Company Snapshot; 18.15.2 Product Portfolio; 18.15.3 Recent Developments; 18.16 Pharmaxis Ltd; 18.16.1 Company Snapshot; 18.16.2 Revenue Analysis; 18.16.3 Product Portfolio; 18.16.4 Recent Developments; 18.17 Redx Pharma Plc.; 18.17.1 Company Snapshot; 18.17.2 Revenue Analysis; 18.17.3 Product Portfolio; 18.17.4 Recent Developments; 18.18 Verona Pharma Plc; 18.18.1 Company Snapshot; 18.18.2 Revenue Analysis; 18.18.3 Product Portfolio; 18.18.4 Recent Developments
19 Questionnaire
20 Related Reports 157
List Of Tables: Table 1 Middle East & Africa Fibrotic Diseases Treatment Market, Pipeline Analysis; Table 2 Middle East & Africa Fibrotic Diseases Treatment Market, By Treatment, 2021-2030 (Usd Thousand); Table 3 Middle East & Africa Medication In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 4 Middle East & Africa Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Usd Thousand); Table 5 Middle East & Africa Organ Transplantation In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 6 Middle East & Africa Oxygen Therapy In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 7 Middle East & Africa Other In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 8 Middle East & Africa Fibrotic Diseases Treatment Market, By Application, 2021-2030 (Usd Thousand); Table 9 Middle East & Africa Idiopathic Pulmonary Fibrosis In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 10 Middle East & Africa Hepatic Cirrhosis In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 11 Middle East & Africa Renal Fibrosis In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 12 Middle East & Africa Cutaneous Fibrosis In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 13 Middle East & Africa Others In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 14 Middle East & Africa Fibrotic Diseases Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 15 Middle East & Africa Hospitals In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 16 Middle East & Africa Specialty Clinics In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 17 Middle East & Africa Academic And Research Institutes In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 18 Middle East & Africa Others In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 19 Middle East & Africa Fibrotic Diseases Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 20 Middle East & Africa Hospital Pharmacy In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 21 Middle East & Africa Retail Pharmacy In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 22 Middle East & Africa Others In Fibrotic Diseases Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 23 Middle East And Africa Fibrotic Diseases Treatment Market, By Country, 2021-2030 (Usd Thousand); Table 24 Middle East And Africa Fibrotic Diseases Treatment Market, By Treatment, 2021-2030 (Usd Thousand); Table 25 Middle East And Africa Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Usd Thousand); Table 26 Middle East And Africa Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Volume); Table 27 Middle East And Africa Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Asp); Table 28 Middle East And Africa Fibrotic Diseases Treatment Market, By Application, 2021-2030 (Usd Thousand); Table 29 Middle East And Africa Fibrotic Diseases Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 30 Middle East And Africa Fibrotic Diseases Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 31 South Africa Fibrotic Diseases Treatment Market, By Treatment, 2021-2030 (Usd Thousand); Table 32 South Africa Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Usd Thousand); Table 33 South Africa Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Volume); Table 34 South Africa Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Asp); Table 35 South Africa Fibrotic Diseases Treatment Market, By Application, 2021-2030 (Usd Thousand); Table 36 South Africa Fibrotic Diseases Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 37 South Africa Fibrotic Diseases Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 38 Saudi Arabia Fibrotic Diseases Treatment Market, By Treatment, 2021-2030 (Usd Thousand); Table 39 Saudi Arabia Products, 2021-2030 (Usd Thousand); Table 40 Saudi Arabia Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Volume); Table 41 Saudi Arabia Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Asp); Table 42 Saudi Arabia Fibrotic Diseases Treatment Market, By Application, 2021-2030 (Usd Thousand); Table 43 Saudi Arabia Fibrotic Diseases Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 44 Saudi Arabia Fibrotic Diseases Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 45 U.A.E Fibrotic Diseases Treatment Market, By Treatment, 2021-2030 (Usd Thousand); Table 46 U.A.E Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Usd Thousand); Table 47 U.A.E Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Volume); Table 48 U.A.E Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Asp); Table 49 U.A.E Fibrotic Diseases Treatment Market, By Application, 2021-2030 (Usd Thousand); Table 50 U.A.E Fibrotic Diseases Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 51 U.A.E Fibrotic Diseases Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 52 Egypt Fibrotic Diseases Treatment Market, By Treatment, 2021-2030 (Usd Thousand); Table 53 Egypt Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Usd Thousand); Table 54 Egypt Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Volume); Table 55 Egypt Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Asp); Table 56 Egypt Fibrotic Diseases Treatment Market, By Application, 2021-2030 (Usd Thousand); Table 57 Egypt Fibrotic Diseases Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 58 Egypt Fibrotic Diseases Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 59 Kuwait Fibrotic Diseases Treatment Market, By Treatment, 2021-2030 (Usd Thousand); Table 60 Kuwait Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Usd Thousand); Table 61 Kuwait Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Volume); Table 62 Kuwait Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Asp); Table 63 Kuwait Fibrotic Diseases Treatment Market, By Application, 2021-2030 (Usd Thousand); Table 64 Kuwait Fibrotic Diseases Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 65 Kuwait Fibrotic Diseases Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 66 Israel Fibrotic Diseases Treatment Market, By Treatment, 2021-2030 (Usd Thousand); Table 67 Israel Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Usd Thousand); Table 68 Israel Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Volume); Table 69 Israel Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Asp); Table 70 Israel Fibrotic Diseases Treatment Market, By Application, 2021-2030 (Usd Thousand); Table 71 Israel Fibrotic Diseases Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 72 Israel Fibrotic Diseases Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 73 Bahrain Fibrotic Diseases Treatment Market, By Treatment, 2021-2030 (Usd Thousand); Table 74 Bahrain Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Usd Thousand); Table 75 Bahrain Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Volume); Table 76 Bahrain Medication In Fibrotic Diseases Treatment Market, By Products, 2021-2030 (Asp); Table 77 Bahrain Fibrotic Diseases Treatment Market, By Application, 2021-2030 (Usd Thousand); Table 78 Bahrain Fibrotic Diseases Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 79 Bahrain Fibrotic Diseases Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 80 Rest Of Middle East And Africa Fibrotic Diseases Treatment Market, By Treatment, 2021-2030 (Usd Thousand) 102
List Of Figures: Figure 1 Middle East & Africa Fibrotic Diseases Treatment Market: Segmentation; Figure 2 Middle East & Africa Fibrotic Diseases Treatment Market: Data Triangulation; Figure 3 Middle East & Africa Fibrotic Diseases Treatment Market: Droc Analysis; Figure 4 Middle East & Africa Fibrotic Diseases Treatment Market: Middle East & Africa Vs Regional Market Analysis; Figure 5 Middle East & Africa Fibrotic Diseases Treatment Market: Company Research Analysis; Figure 6 Middle East & Africa Fibrotic Diseases Treatment Market: Interview Demographics; Figure 7 Middle East & Africa Fibrotic Diseases Treatment Market: Dbmr Market Position Grid; Figure 8 Middle East & Africa Fibrotic Diseases Treatment Market: Market End User Coverage Grid; Figure 9 Middle East & Africa Fibrotic Diseases Treatment Market : Vendor Share Analysis; Figure 10 Middle East & Africa Fibrotic Diseases Treatment Market: Segmentation; Figure 11 Rising Prevalence Of Fibrotic Diseases Is Expected To Drive The Middle East & Africa Fibrotic Diseases Treatment Market Growth In The Forecast Period; Figure 12 Medication Segment Is Expected To Account For The Largest Share Of The Middle East & Africa Fibrotic Diseases Treatment Market In 2023 & 2030; Figure 13 Patient Flow Diagram; Figure 14 Drivers, Restraints, Opportunities And Challenges Of The Middle East & Africa Fibrotic Diseases Treatment Market; Figure 15 Middle East & Africa Fibrotic Diseases Treatment Market By Treatment 2022; Figure 16 Middle East & Africa Fibrotic Diseases Treatment Market By Treatment 2023-2030 (Usd Thousand); Figure 17 Middle East & Africa Fibrotic Diseases Treatment Market By Treatment Cagr (2023-2030); Figure 18 Middle East & Africa Fibrotic Diseases Treatment Market By Treatment Lifeline Curve; Figure 19 Middle East & Africa Fibrotic Diseases Treatment Market: By Application, 2022; Figure 20 Middle East & Africa Fibrotic Diseases Treatment Market: By Application, 2023-2030 (Usd Thousand); Figure 21 Middle East & Africa Fibrotic Diseases Treatment Market: By Application, Cagr (2023-2030); Figure 22 Middle East & Africa Fibrotic Diseases Treatment Market: By Application, Lifeline Curve; Figure 23 Middle East & Africa Fibrotic Diseases Treatment Market: By End User, 2022; Figure 24 Middle East & Africa Fibrotic Diseases Treatment Market: By End User, 2023-2030 (Usd Thousand); Figure 25 Middle East & Africa Fibrotic Diseases Treatment Market: By End User, Cagr (2023-2030); Figure 26 Middle East & Africa Fibrotic Diseases Treatment Market: By End User, Lifeline Curve; Figure 27 Middle East & Africa Fibrotic Diseases Treatment Market: By Distribution Channel, 2022; Figure 28 Middle East & Africa Fibrotic Diseases Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand); Figure 29 Middle East & Africa Fibrotic Diseases Treatment Market: By Distribution Channel, Cagr (2023-2030); Figure 30 Middle East & Africa Fibrotic Diseases Treatment Market: By Distribution Channel, Lifeline Curve; Figure 31 Middle East And Africa Fibrotic Diseases Treatment Market: Snapshot (2022); Figure 32 Middle East And Africa Fibrotic Diseases Treatment Market: By Country (2022); Figure 33 Middle East And Africa Fibrotic Diseases Treatment Market: By Country (2023 & 2030); Figure 34 Middle East And Africa Fibrotic Diseases Treatment Market: By Country (2022 & 2030); Figure 35 Middle East And Africa Fibrotic Diseases Treatment Market: Treatment (2023-2030); Figure 36 Middle East & Africa Fibrotic Diseases Treatment Market: Company Share 2022 (%) 102